Summary
Slices of the rabbit caudate nucleus were preincubated with 3H-dopamine or 3H-choline and then superfused and stimulated electrically. DiPr-5,6-ADTN reduced the stimulation-evoked overflow of tritium over the same concentration range, independently of whether slices had been preincubated with 3H-dopamine or 3H-choline, and the same was true for apomorphine, NPA and pergolide. Three other putative dopamine receptor agonists, namely 3-PPP, DPI and SKF 38393, failed to decrease the evoked overflow of tritium. Each of six antagonists — (−)-sulpiride, (+)-sulpiride, CGP 11109 A, cis-flupentixol, domperidone and corynanthine —increased the evoked overflow over the same concentration range in experiments with 3H-dopamine and in those with 3H-choline. For each of these antagonists except cis-flupentixol, and also for chlorpromazine, haloperidol and rauwolscine, the pA2 values against apomorphine obtained in 3H-dopamine and in 3H-choline experiments were closely similar. The antagonist effect of cis-flupentixol against apomorphine was not purely competitive. (−)-Sulpiride was a more potent antagonist than (+)-sulpiride, and cis-flupentixol was more potent than trans-flupentixol.
This study supplements a previous one in which (±)-sulpiride, metoclopramide and molindone were used as antagonists. It is a functional in vitro approach to receptor characterization, as opposed to radioligand binding studies or in vivo investigations. The results show that a large number of dopamine receptor agonists and antagonists are unable to distinguish between the presynaptic, release-inhibiting dopamine autoreceptors and those postsynaptic dopamine receptors which, when activated, depress the release of acetylcholine. Both receptors can be classified as D2. There was an excellent correlation between pA2 values and the — log K i values of antagonists, taken from the literature, for inhibition of the binding of 3H-spiperone to rat striatal membrane fragments. The correlation supports the view that the sites labelled by 3H-spiperone are true receptors, although the affinities in the binding experiments were consistently lower than the functionally determined affinities in the intact tissue.
Similar content being viewed by others
Abbreviations
- CGP 11109 A:
-
N-[(1-ethyl-2-pyrrolidinyl)methyl]-2,6-dimethoxy-nicotinamide
- DiPr-5,6-ADTN:
-
2-(N,N-di-n-propyl) amino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene
- DPI:
-
(3,4-dihydroxyphenylimino)-2-imidazolidine
- NPA:
-
N-n-propyl-norapomorphine
- 3-PPP:
-
3-(3-hydroxyphenyl)-N-n-propyl-piperidine
- SKF 38393:
-
2,3,4,5-tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
References
Andén NE, Grabowska M (1976) Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur J Pharmacol 39:275–282
Arbilla S, Langer SZ (1981) Stereoselectivity of presynaptic autoreceptors modulating dopamine release. Eur J Pharmacol 76:345–351
Creese I (1982) Dopamine receptors explained. Trends Neurosci 5:40–43
Creese I, Stewart K, Snyder SH (1979) Species variations in dopamine receptor binding. Eur J Pharmacol 60:55–66
Dray A (1979) The striatum and substantia nigra: a commentary on their relationships. Neuroscience 4:1407–1439
Haubrich DR, Pflueger AB (1982) The autoreceptor control of dopamine synthesis. An in vitro and in vivo comparison of dopamine agonists. Mol Pharmacol 21:114–120
Helmreich I, Reimann W, Hertting G, Starke K (1982) Are presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different?. Neuroscience 7:1559–1566
Hertting G, Zumstein A, Jackisch R, Hoffmann I, Starke K (1980) Modulation by endogenous dopamine of the release of acetylcholine in the caudate nucleus of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 315:111–117
Hjorth S, Carlsson A, Wikström H, Lindberg P, Sanchez D, Hacksell U, Arvidsson LE, Svensson U, Nilsson JG (1981) 3-PPP, a new centrally acting DA-receptor agonist with selectivity for autoreceptors. Life Sci 28:1225–1238
Horn AS, de Vries J, Dijkstra D, Mulder AH (1982) Is TL-99 a selective presynaptic dopamine receptor agonist? Eur J Pharmacol 83:35–45
Lehmann J, Langer SZ (1982) Dopamine autoreceptors differ pharmacologically from postsynaptic dopamine receptors: effects of (−)-N-(2-chloroethyl)-norapomorphine. Eur J Pharmacol 77:85–86
Lehmann J, Arbilla S, Langer SZ (1981) Dopamine receptor mediated inhibition by pergolide of electrically-evoked 3H-dopamine release from striatal slices of cat and rat: slight effect of ascorbate. Naunyn-Schmiedeberg's Arch Pharmacol 317:31–35
Scatton B (1982) Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity. J Pharmacol Exp Ther 220: 197–202
Scatton B, Zivkovic B, Dedek J (1980) Antidopaminergic properties of yohimbine. J Pharmacol Exp Ther 215:494–499
Seeman P (1981) Brain dopamine receptors. Pharmacol Rev 32: 229–313
Sibley DR, Leff SE, Creese I (1982) Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors. Life Sci 31:637–645
Starke K (1979) Presynaptic regulation of release in the central nervous system. In: Paton DM (ed) The release of catecholamines from adrenergic neurons. Pergamon Press, Oxford New York, pp 143–183
Starke K (1981 a) Stationen im Lebensweg des neurotransmitters Dopamin. Freiburger Universitätsblätter 20:142–145
Starke K (1981 b) Presynaptic receptors. Ann Rev Pharmacol Toxicol 21:7–30
Starke K (1981 c) α-Adrenoceptor subclassification. Rev Physiol Biochem Pharmacol 88:199–236
Starke K, Adelung C (1982) Further functional characterization of two dopamine receptors in rabbit caudate nucleus. Naunyn-Schmiedeberg's Arch Pharmacol 319:R63
Starke K, Reimann W, Zumstein A, Hertting G (1978) Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 305:27–36
Stoof JC, Horn AS, Mulder AH (1980) Simultaneous demonstration of the activation of presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in vitro by N,N-dipropyl-5,6-ADTN. Brain Res 196:276–281
Stoof JC, de Boer T, Sminia P, Mulder AH (1982) Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of γ-aminobutyric acid, glutamate or serotonin. Eur J Pharmacol 84:211–214
Van Oene JC, Houwing HA (1982) Evidence that the purported dopaminergic agonist (3,4-dihydroxyphenylimino)-2-imidazolidine (DPI) may reduce rat striatal dopamine turnover by an α2-adrenergic mechanism. Eur J Pharmacol 81:75–87
Vizi ES, Hársing LG, Knoll J (1977) Presynaptic inhibition leading to disinhibition of acetylcholine release from interneurons of the caudate nucleus: effects of dopamine, β-endorphin and D-Ala2-Pro5-enkephalinamide. Neuroscience 2:953–961
Weitzell R, Tanaka T, Starke K (1979) Pre- and postsynaptic effects of yohimbine stereoisomers on noradrenergic transmission in the pulmonary artery of the rabbit. Naunyn-Schmiedeberg's Arch Pharmacol 308:127–136
Winne D (1967) Zur Auswertung von Versuchsergebnissen. 1. Die statistische Bearbeitung von Meßergebnissen Arzneimittelforschung 17:93–97
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Starke, K., Späth, L., Lang, J.D. et al. Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in the rabbit caudate nucleus. Naunyn-Schmiedeberg's Arch. Pharmacol. 323, 298–306 (1983). https://doi.org/10.1007/BF00512467
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00512467